{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fiambio.simplecast.com%2Fepisodes%2Fat-last-covid-treatments-ZUoUz6AE","width":444,"version":"1.0","type":"rich","title":"At Last, COVID Treatments","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/9b3967de-d938-42f2-b54e-99b29c007c9b/edf95499-0c7d-4519-8809-c86b3b8795c1/bio-podcast-logo-1.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/c4a0a941-be2c-4176-895f-4f664b0c5d09\" height=\"200\" width=\"100%\" title=\"At Last, COVID Treatments\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Covid threatens those whose immune systems can’t make enough neutralizing antibodies to fight off the viral invaders. But what if scientists could make super-potent antibodies in the lab and infuse them into newly infected patients? That’s exactly what the first FDA-authorized coronavirus antibody treatment has achieved. Its maker, Eli Lilly, has generated clinical evidence that their therapy can significantly reduce COVID hospitalization rates when taken early.\n"}